BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25955083)

  • 21. Dendritic cells decreased the concomitant expanded Tregs and Tregs related IL-35 in cytokine-induced killer cells and increased their cytotoxicity against leukemia cells.
    Pan Y; Tao Q; Wang H; Xiong S; Zhang R; Chen T; Tao L; Zhai Z
    PLoS One; 2014; 9(4):e93591. PubMed ID: 24705499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biological characteristics of PHA-induced CIK cells and its killing activity to K562 cells].
    Huang MZ; Bai J; Li FS; Liu YL; Li MM; Li YH; Zhang LS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):64-8. PubMed ID: 24598653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Proliferation and cytotoxicity of RetroNectin-activated cytokine-induced killer cells against cisplatin-resistant lung carcinoma cell].
    Ren W; Wang Z
    Sheng Wu Gong Cheng Xue Bao; 2008 Aug; 24(8):1373-80. PubMed ID: 18998538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inducible costimulator (ICOS) enhances the cytolytic activity of cytokine-induced killer cells against gallbladder cancer in vitro and in vivo.
    Wang J; He M; Shi W; Sha H; Feng J; Wang S; Wang Y
    Cancer Invest; 2009 Mar; 27(3):244-50. PubMed ID: 19194830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological Character of RetroNectin Activated Cytokine-Induced Killer Cells.
    Han L; Shang YM; Song YP; Gao QL
    J Immunol Res; 2016; 2016():5706814. PubMed ID: 27433478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of humanized interleukin 21 on anti-leukemic activity of cytokine induced killer cells and the mechanism].
    Zhao N; Zhao MF; Rajbhandary S; Lu WY; Zhu HB; Xiao X; Deng Q; Li YM
    Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):823-8. PubMed ID: 23384903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo distribution and antitumor effect of infused immune cells in a gastric cancer model.
    Du X; Jin R; Ning N; Li L; Wang Q; Liang W; Liu J; Xu Y
    Oncol Rep; 2012 Nov; 28(5):1743-9. PubMed ID: 22948809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A CTLA-4 blocking strategy based on Nanoboby in dendritic cell-stimulated cytokine-induced killer cells enhances their anti-tumor effects.
    Wang W; Wang X; Yang W; Zhong K; He N; Li X; Pang Y; Lu Z; Liu A; Lu X
    BMC Cancer; 2021 Sep; 21(1):1029. PubMed ID: 34525966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antitumor effects of cocultured dendritic cells and cytokine-induced killer cells on lung cancer in vitro and in vivo].
    Yang XJ; Huang JA; Lei W; Zhu YB; Zhang XG
    Ai Zheng; 2006 Nov; 25(11):1329-33. PubMed ID: 17094896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Autologous CIK cell infusion promotes amplification ability of CD3⁺ CD56⁺ cells when re-preparation from patients with malignant tumors].
    Yu H; Sun Y; Lin D; Li C; Chen W; Ma D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):748-53, 758. PubMed ID: 25001943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-6 inhibits regulatory T cells and improves the proliferation and cytotoxic activity of cytokine-induced killer cells.
    Lin G; Wang J; Lao X; Wang J; Li L; Li S; Zhang J; Dong Y; Chang AE; Li Q; Li S
    J Immunother; 2012 May; 35(4):337-43. PubMed ID: 22495391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic potential of IL-15-activated cytokine-induced killer cells against human neuroblastoma cells.
    Cappel C; Huenecke S; Suemmerer A; Erben S; Rettinger E; Pfirrmann V; Heinze A; Zimmermann O; Klingebiel T; Ullrich E; Bader P; Bremm M
    Pediatr Blood Cancer; 2016 Dec; 63(12):2230-2239. PubMed ID: 27433920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects and mechanism on anti-leukemic activity of cytokine-induced killer cells with an endogenous expression of interleukin-21].
    Zhao N; Zhao MF; Rajbhandary S; Lu WY; Zhu HB; Ma L; You Q; Xiao X; Deng Q; Li YM
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(4):293-9. PubMed ID: 23578511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The cytotoxicity of CIK/NK cells stimulated by K562-DC fusion vaccines in NOD/SCID mice model for human erythroleukemia].
    Li Y; Huang SL; Zhang XC; Fang JP; Wu YF; Wei J; Huang WG; Zhou DH; Huang K; Lin YC
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jan; 29(1):39-43. PubMed ID: 18512314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Short-term curative efficacy of autologous cytokine induced killer cells combined with low-dose IL-2 regimen containing immune enhancement by thymic peptide in elderly patients with B-cell chronic lymphocytic leukemia].
    Cai LL; Yang Y; Yang B; Zhu HL; Lu XC; Zhang WY; Yu RL; Chi XH; Wang Y; Dai HR; Han WD; Fan H; Li SX; Liu Y; Ran HH; Lin J; Tuo S; Tuo CW; Zhang F; Cao JP; Yao SQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):564-70. PubMed ID: 22739156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy with cytokine-induced killer cells in metastatic renal cell carcinoma.
    Su X; Zhang L; Jin L; Ye J; Guan Z; Chen R; Guo T
    Cancer Biother Radiopharm; 2010 Aug; 25(4):465-70. PubMed ID: 20701541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokine-induced killer cells against autologous CLL: direct cytotoxic effects and induction of immune accessory molecules by interferon-gamma.
    Kornacker M; Moldenhauer G; Herbst M; Weilguni E; Tita-Nwa F; Harter C; Hensel M; Ho AD
    Int J Cancer; 2006 Sep; 119(6):1377-82. PubMed ID: 16642465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of tumor-dendritic cell fusion vaccines on the cytotoxicity of CIK/NK cells from cord blood].
    Li Y; Huang SL; Wu YF; Wei J; Meng Y; Zhou DH; Bao R
    Zhonghua Xue Ye Xue Za Zhi; 2005 May; 26(5):269-72. PubMed ID: 15949286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-culture of dendritic cells and cytokine-induced killer cells effectively suppresses liver cancer stem cell growth by inhibiting pathways in the immune system.
    Yang T; Zhang W; Wang L; Xiao C; Wang L; Gong Y; Huang D; Guo B; Li Q; Xiang Y; Nan Y
    BMC Cancer; 2018 Oct; 18(1):984. PubMed ID: 30326865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimized protocols for generation of cord blood-derived cytokine-induced killer/natural killer cells.
    Li Y; Schmidt-Wolf IG; Wu YF; Huang SL; Wei J; Fang J; Huang K; Zhou DH
    Anticancer Res; 2010 Sep; 30(9):3493-9. PubMed ID: 20944128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.